We have previously shown that the secreted ECM protein transforming growth factor beta induced (TGFBI) sensitizes ovarian cancer cells to the mitotic inhibitor paclitaxel by regulating microtubule stability via integrin-mediated FAK and RhoA activation [1,3]. The gene discussed is TGFBI; the disease is ovarian cancer.